Study of Letrozole With or Without BYL719 or Buparlisib, for the Neoadjuvant Treatment of Postmenopausal Women

NCT01923168 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

340

Enrollment

INDUSTRY

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: alpelisib
DRUG: buparlisib
DRUG: Placebo

Sponsor

Novartis Pharmaceuticals